Home > 暂无记录 暂无记录 公司动态

公司动态


  • IWR-1-endo EY0429

    IWR-1-endo, an active endo form of IWR-1, is a small molecule inhibitor for Wnt/β-catenin signaling via the inhibition of tankyrase. IWR-1-endo是一种Wnt通路抑制剂,IC50为180 nM,诱导Axin2蛋白水平,且促进β-catenin磷酸化。

    More
  • FH535 EY0435

    FH535, a dual small-molecule inhibitor of Wnt/β-catenin signaling pathway and the peroxisome proliferator-activated receptor (PPAR), shows potent inhibition of various cancers. FH535能双重抑制Wnt/beta-catenin和PPAR信号通路。

    More
  • WY-14643 EY0400

    WY-14643 (Pirinixic Acid), a moderate dual PPARα/γ activator, inhibits neuroinflammation and oxidative stress, and also possesses antidepressive activities. WY-14643 (Pirinixic Acid)是一种有效的过氧化物酶体增殖子和PPARα激活剂,EC50为1.5 μM。

    More
  • Entinostat EY0413

    Entinostat (MS-27-275, MS-275, SNDX-275) an orally class I histone deacetylase (HDAC)-specific inhibitor, is currently in clinical trials.

    More
  • Tamoxifen Citrate EY0415

    Tamoxifen citrate, a selective non-steroidal estrogen receptor antagonist, was approved by FDA as a drug that is utilized in the treatment of estrogen receptor–positive breast cancer. Tamoxifen Citrate是一种雌激素受体拮抗剂,与雌激素竞争性结合。

    More
  • Current page311, Total Pages415, Total Record2075 First Prev 309310311312313 Next Last Goto